Alan Main
Net worth: 613 738 $ as of 2024-03-30
Profile
Alan J.
Main served as the President & Chief Executive Officer at Coelacanth Corp.
from 2000 to 2001.
He then worked as the Senior Vice President-US Research at Novartis Pharmaceuticals Corp.
Following that, he held the position of Executive Vice President-Pharmaceutical Research at Lexicon Pharmaceuticals, Inc. from 2007 to 2015.
Dr. Main completed his undergraduate degree at the University of Aberdeen and obtained a doctorate from The University of Liverpool.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-17 | 255,724 ( 0.10% ) | 613 738 $ | 2024-03-30 |
Former positions of Alan Main
| Companies | Position | End |
|---|---|---|
Coelacanth Corp.
 Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Coelacanth Corp. is a company that researches drug development. The company is based in East Windsor, NJ. The company was founded by Robert Grubbs. Coelacanth was acquired by Lexicon Pharmaceuticals, Inc. on 2001-07-12 for $31.9 million. | Chief Executive Officer | 2001-06-30 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
| LEXICON PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2015-03-10 |
Training of Alan Main
| University of Aberdeen | Undergraduate Degree |
| The University of Liverpool | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Coelacanth Corp.
Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Coelacanth Corp. is a company that researches drug development. The company is based in East Windsor, NJ. The company was founded by Robert Grubbs. Coelacanth was acquired by Lexicon Pharmaceuticals, Inc. on 2001-07-12 for $31.9 million. | Commercial Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
- Stock Market
- Insiders
- Alan Main
